Guidelines on the drug treatment of patients with type II diabetes were published last month by NICE. They clarify the place of the newer anti-hyperglycaemic drugs and expand the indications for insulin analogues. Natasha Jacques summarises the key changes.
Whether we practice ‘clinical pharmacy’, ‘public health’ or ‘pharmaceutical care’, our developing roles remain underpinned by the pharmaceutical sciences, says Catherine Duggan.
Therapeutic drug monitoring (TDM) is important for the optimal dosing of a wide range of drugs. This article introduces the principles of TDM and is followed by a case study. By David Jones.
This article describes the application of therapeutic drug monitoring to achieve optimal dosing of phenytoin in an elderly patient with co-morbid conditions. By David Jones.
Montelukast is a leukotriene receptor antagonist licensed for the prophylaxis of asthma in children. Here, the North Central London Formulary and Medicines Management Group assess the efficacy of montelukast in addition to, and as an alternative to inhaled corticosteroids. By Anthony Grosso, Pritesh Bodalia and Simon Keady.
Medicines spend in secondary care is likely to be scrutinised increasingly in the future. Ron Pate and Ray Fitzpatrick explain the need for a national data set and hospital prescribing indicators.
Alia Gilani has been working as a health inequalities pharmacist for the past seven years. This article describes recent advances in her work, which now includes a service for all ethnic minorities taking long-term medication and help for asylum seekers. By Shona Kirk.
Prescriber’s Corner describes situations encountered by pharmacist prescribers and invites you to consider clinical decisions about the patient. In this case, you are reviewing a patient with osteoporosis who is taking oral hypoglycaemic drugs for type II diabetes. By Andrew Husband and Anne Marie Bailey.
Hypoglycaemia in patients with diabetes is often poorly treated and documented. Elizabeth Hackett describes steps taken at a large teaching hospital to improve monitoring and staff education.
Examples of good leadership and innovative research were showcased at this year’s joint Guild of Healthcare Pharmacists and UK Clinical Pharmacy Association conference. By Shona Kirk.
The importance of patient and staff engagement was discussed at this year’s Guild of Healthcare Pharmacists Procurement and Distribution Interest Group summer symposium. By Shona Kirk.
Decriminalisation of dispensing errors could be viewed as reducing the responsibilities of pharmacists to their patients. The priority should be the safety of the dispensing process, says Philip Brown.